Researchers identified ten ferroptosis-related lncRNAs associated with AML prognosis. These lncRNAs were used to construct a prognostic model, effectively predicting patient survival. High-risk ...

This collection describes the impact of pre-transplant molecular measurable residual disease (MRD) on acute myeloid leukemia (AML) prognosis. The original pre-MEASURE study demonstrated the ...

The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a study conducted by the Karl Landsteiner University of Health Sciences (KL ...

This study analyzed a prospectively collected cohort of 410 AML cases. It was led by Dr. Guilin Tang, and a team of experts from the MD Anderson Cancer Center, and is the first study known to utilize ...

and poor prognosis compared to subjects with no detectable CAG. Based on the OGM findings, clinical researchers found higher than anticipated rates of CAG in AML (16% of cases overall and ...

India had the highest number of cases of AML in 2021. Effective cancer care depends on three critical factors: early screening, accurate diagnosis to determine prognosis and to tailor therapeutic ...

Across two trials, 9 of 10 frontline AML patients achieved remission when treated with mipletamig in combination with the standard of careTriplet Combination with mipletamig continues to outperform do ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with ...

which can improve the clinical outcomes and prognosis among people diagnosed with AML, many of whom cannot tolerate intensive treatment.” In February 2022, the FDA granted orphan drug ...